Gestational Diabetes Mellitus and Cardiovascular Disease: The Role of Vascular Dysfunction
NCT ID: NCT00998712
Last Updated: 2013-08-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
88 participants
OBSERVATIONAL
2009-08-31
2014-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Black women in the third trimester of a pregnancy complicated by gestational diabetes.
No interventions assigned to this group
2
Black women in the third trimester of a normal, uncomplicated pregnancy.
No interventions assigned to this group
3
White women in the third trimester of a pregnancy complicated by gestational diabetes.
No interventions assigned to this group
4
White women in the third trimester of a normal, uncomplicated pregnancy.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18-40 years of age,
* Body mass index \< 35 kg/m2
* History of regular menstrual cycles,
* Are currently pregnant and in third trimester of pregnancy (after 24 weeks gestational age)
* Have no pregnancy-associated complications to-date
* Are in good health free of hypertension, as well as thyroid, cardiac, or renal disease.
Exclusion Criteria
* Are taking potentially vasoactive medications
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Brigham and Women's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rhonda Bentley-Lewis, MD
Rhonda Bentley-Lewis, MD, MBA, MMSc
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Brigham and Women's Hospital, Massachusetts General Hospital
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2009P001255
Identifier Type: -
Identifier Source: org_study_id